MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Axial myoclonus and cerebellar ataxia in a patient with mutation in ADCK3

    M. Gultekin (Kayseri, Turkey)

    Objective: We herein report a 20 years old female, who presented with axial myoclonus, dysarthria and gait ataxia. Background: Autosomal recessive  ataxias are a group…
  • MDS Virtual Congress 2020

    Ataxia and action myoclonus with biallelic mutations in ATP13A2 gene

    A. Sánchez-Rodríguez, I. González-Aramburu, M. Sierra, A.L Pelayo-Negro, M. Corral-Juan, X. Farré, I. Sánchez, A. Matilla-Dueñas, J. Infante (Santander, Spain)

    Objective: Here we report a patient with late-onset ataxia-myoclonus syndrome harboring mutations in the ATP13A2 gene. Background: Mutations in ATP13A2 gene have been causally associated…
  • MDS Virtual Congress 2020

    Non-Ketotic Hyperglycemic Hemichorea as an initial manifestation of type 2 diabetes

    P. Karau, J. Hooker, G. Mbijiwe (Meru, Kenya)

    Objective: To diagnose and characterize Non-ketotic Hyperglycemic Hemichorea as a first symptom of type 2 Diabetes using phenomenology and imaging Background: Non-Ketotic Hyperglycemic Hemichorea is…
  • MDS Virtual Congress 2020

    Long-term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia

    M. Sajatovic, A. Wilhelm, S. Finkbeiner, H. Barkay, N. Chaijale, N. Gross, M. Gordon (Cleveland, OH, USA)

    Objective: To assess the long-term safety and efficacy of deutetrabenazine in younger (<55 years) and older (≥55 years) patients with tardive dyskinesia (TD). Background: TD…
  • MDS Virtual Congress 2020

    Patient Perspective of Tardive Dyskinesia: Results from a Social Media Listening Study

    L. Lundt, M. Farrar, E. Franey, C. Yonan (San Diego, CA, USA)

    Objective: To use social media listening (SML) to understand the impact of symptoms on patients with assumed/self-reported tardive dyskinesia (TD). Background: TD is a persistent…
  • MDS Virtual Congress 2020

    Thalamic Deep Brain Stimulation for Acquired Dystonia in Children and Young Adults: A Phase I Clinical Trial

    M. San Luciano, A. Viehoever, I. Bledsoe, K. Dodenhoff, M. Gittings, A. Viser, C. Racine-Belkoura, C. Pereira, S. Wang, P. Starr, J. Ostrem (San Francisco, CA, USA)

    Objective: To evaluate preliminary efficacy and safety of bilateral ventralis oralis posterior (VOP) deep brain stimulation (DBS) for the treatment of acquired dystonia in children…
  • MDS Virtual Congress 2020

    Non-Motor Symptoms In Chinese Patients With Isolated Generalized Dystonia: A Case-Control Study

    S.L Li, X.H Wan, L. Wang, YY. Mai, L. Qiao, DD. Zhang (Beijing, China)

    Objective: To explore non-motor symtoms in Chinese patients with isolated generalized dystonia. Background: Previous studies have indicated that non-motor symptoms are primary problems in focal…
  • MDS Virtual Congress 2020

    The Impact of the Sensory Trick on Gating Multimodal Afferents in Cervical Dystonia

    F. Brugger, J. Michelis, J. Walch, G. Kägi (St. Gallen, Switzerland)

    Objective: To investigate how ST modulate the postural sway in patients with idiopathic cervical dystonia (iCD) when proprioceptive and vestibular stimulation are provided simultaneously. Background: We…
  • MDS Virtual Congress 2020

    DystoniaNet: Neural Biomarker-Based Platform for Dystonia Diagnosis using Deep Learning

    D. Valeriani, K. Simonyan (Boston, MA, USA)

    Objective: Development and validation of a deep learning algorithmic platform for the identification of a microstructural biomarker for objective, accurate, and rapid diagnosis of dystonia.…
  • MDS Virtual Congress 2020

    Pesticide Exposure in PD with and without Genetic Risk Variants

    E. Brown, C. Meng, S. Goldman, C. Tanner (San Francisco, CA, USA)

    Objective: To evaluate the association between pesticide exposure and development of Parkinson’s disease (PD) in idiopathic and genetic PD, and to determine whether clinical features…
  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley